Handbook of Dialysis Therapy

PART I: Dialysis Therapy for Adults<br>Section 1: Overview of ESKD<br>1 Demographics of the End-Stage Renal Disease Patient<br>2 Uremic Toxicity<br>3 Initiation of Dialysis Therapy<br>Section 2: Hemodialysis<br>4 Urea Kinetic Modeling for Guiding Hemodialysis Therapy in Adults<br>5 The Dialysis Prescription<br>6 Selecting a Dialyzer: Technical and Clinical Considerations<br>7 Water Treatment Equipment for In-Center Hemodialysis<br>8 Dialysate Composition<br>9 Safety Monitors in Hemodialysis<br>10 Methods of Hemodialysis Anticoagulation<br>11 Common Clinical Problems in Hemodialysis<br>12 Hemofiltration and Hemodiafiltration<br>13 Wearable and Implantable Renal Replacement Therapy<br>14 Home Preparation and Installation for Home Hemodialysis<br>15 Vascular Access<br>16 Cannulation of Arteriovenous Vascular Access: Science and Art<br>17 Central Venous Access for Hemodialysis<br>18 Noninfectious Complications From Vascular Access<br>19 Infectious Complications From Vascular Access<br>Section 3: Peritoneal Dialysis<br>20 Determination of Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis Prescriptions<br>21 Peritoneal Dialysis Cyclers and Other Mechanical Devices<br>22 Peritoneal Dialysis Solutions<br>23 Solute Management With Peritoneal Dialysis<br>24 Volume Management With Peritoneal Dialysis<br>25 Peritoneal Access Devices, Placement Techniques, and Maintenance<br>26 Peritoneal Catheter Exit Site and Tunnel Infections<br>27 Peritonitis in Peritoneal Dialysis<br>28 Abdominal Hernias With Peritoneal Dialysis<br>29 Dialysate Leaks with Peritoneal Dialysis<br>30 Hydrothorax and Peritoneal Dialysis<br>31 Abdominal Catastrophes, Peritoneal Eosinophilia, and Other Unusual Events in Peritoneal Dialysis<br>32 Metabolic Complications of Peritoneal Dialysis<br>Section 4: Management of Uremic Complications<br>33 Acid–Base Homeostasis in Dialysis<br>34 Nutritional Management of Hemodialysis Patients<br>35 Intradialytic Parenteral Nutrition and Intraperitoneal Nutrition<br>36 Nutritional Management in Peritoneal Dialysis<br>37 Anemia and Its Treatment in Patients With End-Stage Kidney Disease<br>38 Resistance to Erythropoiesis Stimulating Agent (ESA) Treatment<br>39 Chronic Kidney Disease–Mineral and Bone Disorder<br>40 Phosphate Management in Patients with End-Stage Kidney Disease<br>41 Use of Vitamin D Sterols and Calcimimetics in Patients With End-Stage Renal Disease<br>42 Parathyroidectomy<br>43 Acquired Cystic Kidney Disease<br>Section 5: Management of Co-Existing Illnesses and Special Populations<br>44 The Challenges of Blood Pressure Control in Hemodialysis Patients<br>45 Arrhythmias in Hemodialysis Patients<br>46 Management of Ischemic Heart Disease, Heart Failure, and Pericarditis in Patients Undergoing Long-Term Dialysis<br>47 Avoidance and Treatment of Cardiovascular Disease in Dialysis<br>48 Management of Dyslipidemia in Long-Term Dialysis Patients<br>49 End-Stage Kidney Failure in the Diabetic Patient<br>50 Care of Elderly Dialysis and End-Stage Kidney Disease Patients<br>51 Liver Disease and Gastrointestinal Disorders in Dialysis Patients<br>52 Abnormalities of Thyroid Function in Chronic Dialysis Patients<br>53 Care of the Human Immunodeficiency Virus–Infected End-Stage Kidney Disease Patient<br>54 COVID-19 and Dialysis Patients<br>55 Psychosocial Issues in Patients Treated With Dialysis<br>56 Evaluation and Treatment of Sexual Dysfunction<br>57 Pregnancy in Dialysis Patients<br>58 Principles of Drug Usage in Dialysis Patients<br>59 Medication Management<br>60 Physical Activity, Function, and Exercise-Based Rehabilitation for People on Dialysis<br>61 Physical, Psychosocial, and Vocational Rehabilitation of Patients Undergoing Long-Term Dialysis<br>62 Preventive Care in End-Stage Renal Disease<br>Section 6: Systems Management for the Care of Dialysis Patients<br>63 Ethical Considerations in the Care of Dialysis Patients: The New Paradigm<br>64 Improving Outcomes for End-Stage Renal Disease Patients: Shifting the Quality Paradigm<br>65 Quality, Safety, Accountability, and Medical Director Responsibilities<br>66 Application of Telemedicine to Kidney Failure Patients<br>Section 7: Acute Kidney Injury and Poisonings<br>67 Continuous Renal Replacement Therapies for Acute Kidney Injury<br>68 Anticoagulation for Continuous Renal Replacement Therapy<br>69 Treatment of Poisoning with Extracorporeal Methods<br>PART II: Dialysis Therapy for Children<br>70 Vascular Access and Peritoneal Dialysis Catheter Placement in Children<br>71 Infant Hemodialysis<br>72 Urea Kinetic Modeling for Hemodialysis Prescription in Children<br>73 Alternate Hemodialysis Prescriptions in Children<br>74 Anticoagulation in Children Undergoing Hemodialysis, Continuous Renal Replacement Therapy, or Apheresis Therapy<br>75 Prescribing Peritoneal Dialysis in Children<br>76 Nutritional Management of Children Undergoing Peritoneal Dialysis<br>77 Peritoneal Dialysis in Neonates and Infants<br>78 Dialysis for Inborn Errors of Metabolism<br>79 Neurocognitive Function in Pediatric Dialysis<br>80 Growth in Children With End-Stage Kidney Disease<br>81 Adequacy of Peritoneal Dialysis/Assessing Peritoneal Function in Pediatric Patients<br>82 Continuous Renal Replacement Therapy in Pediatric Patients<br>83 Prevention and Treatment of Bone Disease in Pediatric Dialysis Patients<br>84 Management of Anemia in Children Undergoing Dialysis<br>85 Prevention and Treatment of Cardiovascular Complications in Children Undergoing Dialysis<br>86 Infectious Complications in Children Undergoing Dialysis<br>87 Caring for the Teenager in an Adult Unit<br>Index